Literature DB >> 11207990

Epidemiology of Helicobacter pylori infection in children: a serologic study of the Kyushu region in Japan.

Y Yamashita1, T Fujisawa, A Kimura, H Kato.   

Abstract

BACKGROUND: The prevalence of Helicobacter pylori infection in children varies as a function of socioeconomic development, with low rates in developed countries and high rates in developing countries. The prevalence of H. pylori infection in Japanese children is unknown.
METHODS: The present study examined the effect of living conditions on the prevalence of H. pylori infection in children. We determined the prevalence of H. pylori infection in healthy children of the Kyushu region in Japan and compared it with the prevalence in institutionalized children with severe neurologic illness. Serum concentrations of anti-H. pylori IgG antibody were measured by an enzyme-linked immunosorbent assay in 336 healthy children and 56 patients with severe neurologic impairment. An antibody concentration > 50 units/mL was taken as evidence of infection.
RESULTS: The prevalence of H. pylori seropositivity in healthy children increased with age (P < 0.0001) and was 29% in children 15-19 years of age. This value is slightly higher than prevalences reported in developed countries (5-15%), but is lower than in developing countries (30-60%). Seropositivity did not vary with respect to gender, water supply or location of housing. Helicobacter pylori seropositivity was more prevalent among institutionalized children aged 5-19 years than their healthy counterparts (P < 0.005).
CONCLUSIONS: The intermediate prevalence of H. pylori seropositivity in healthy children between that measured in developed and developing countries is consistent with the socioeconomic 'westernization' of Japan.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207990     DOI: 10.1046/j.1442-200x.2001.01337.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  7 in total

1.  Effect of oxidizing disinfectants (chlorine, monochloramine, and ozone) on Helicobacter pylori.

Authors:  Katherine H Baker; John P Hegarty; Brady Redmond; Nathan A Reed; Diane S Herson
Journal:  Appl Environ Microbiol       Date:  2002-02       Impact factor: 4.792

2.  Seroprevalence of Helicobacter pylori in dyspeptic patients and its relationship with HIV infection, ABO blood groups and life style in a university hospital, Northwest Ethiopia.

Authors:  Feleke Moges; Afework Kassu; Getahun Mengistu; Solomon Adugna; Berhanu Andualem; Takeshi Nishikawa; Fusao Ota
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

3.  H. pylori-infection and antibody immune response in a rural Tanzanian population.

Authors:  Sam M Mbulaiteye; Benjamin D Gold; Ruth M Pfeiffer; Glen R Brubaker; John Shao; Robert J Biggar; Michie Hisada
Journal:  Infect Agent Cancer       Date:  2006-09-14       Impact factor: 2.965

4.  Changing trends in the prevalence of H. pylori infection in Japan (1908-2003): a systematic review and meta-regression analysis of 170,752 individuals.

Authors:  Chaochen Wang; Takeshi Nishiyama; Shogo Kikuchi; Manami Inoue; Norie Sawada; Shoichiro Tsugane; Yingsong Lin
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

5.  Prevalence of Helicobacter pylori in children and their family members in a district in Turkey.

Authors:  Abdullah Ceylan; Ercan Kirimi; Oğuz Tuncer; Kürşat Türkdoğan; Sevil Ariyuca; Nesrin Ceylan
Journal:  J Health Popul Nutr       Date:  2007-12       Impact factor: 2.000

Review 6.  Helicobacter Pylori associated global gastric cancer burden.

Authors:  Sam M Mbulaiteye; Michie Hisada; Emad M El-Omar
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

7.  Helicobacter pylori colonization in Nepal; assessment of prevalence and potential risk factors in a hospital-based patient cohort.

Authors:  Shamshul Ansari; Rajendra Gautam; Hari Prasad Nepal; Shankar Nand Subedi; Sony Shrestha; Fuleshwar Mandal; Brihaspati Rimal; Muni Raj Chhetri
Journal:  BMC Res Notes       Date:  2016-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.